Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Class action certified in US investor lawsuit against Wyeth/Pfizer over Pristiq

This article was originally published in Scrip

Executive Summary

US District Court Judge Richard Sullivan granted class action status for a lawsuit that alleges Wyeth misled investors about the safety of depression drug Pristiq (desvenlafaxine), causing the company's stock price to tumble when the US FDA issued a negative "approvable letter" regarding the treatment of vasomotor symptoms associated with menopause.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC018806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel